My sources say that its the ASX that is delaying everything. ASX supposedly combing through every detail of the prospectus. Won't be too long but exact timing is hard to tell
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
